Beijing
China
8
2018-12-20
4
2017-11-14
These are the the leading inventors for applications assigned to Protgen Ltd.:
Protgen Ltd. based in Beijing, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF
#2 | 2015-09-17 ✅ Patent 9,815,906 granted on 2017-11-14Method of inhibiting or treating cancer metastasis
#3 | 2014-02-27CONJUGATE ANGIOSTATION OR ITS FRAGMENT, THE METHOD OF PRODUCING THE CONJUGATE AND USE THEREOF
#4 | 2014-02-06 ✅ Patent 10,054,590 granted on 2018-08-21Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and therapy
#5 | 2013-09-19 ✅ Patent 8,975,030 granted on 2015-03-10Method for cancer detection
#6 | 2013-01-24USE OF NUCLEOLIN AS A BIOMARKER FOR LYMPHANGIOGENESIS IN CANCER PROGNOSIS AND THERAPY
#7 | 2012-03-15 ✅ Patent 8,389,684 granted on 2013-03-05Tumor biomarker
#8 | 2010-07-22CONJUGATE COMPRISING ANGIOSTATION OR ITS FRAGMENT, THE METHOD FOR PRODUCING THE CONJUGATE AND USE THEREOF
Also check out Protgen Ltd.'s (Beijing, China) applicant profile with 3 patent applications submitted.
6083 ⎘